original ) (raw )Author Reply: About the discrepancies between consensus documents, clinical practice guidelines, and legal regulations in the treatment of type 2 diabetes
Carlos Morillas
Nefrologia: publicacion oficial de la Sociedad Espanola Nefrologia
View PDFchevron_right
Improved glycaemic control with metformin–glibenclamide combined tablet therapy (Glucovance®) in Type 2 diabetic patients inadequately controlled on metformin
Lehert Philippe
Diabetic Medicine, 2002
View PDFchevron_right
URINE ALBUMIN-TO-CREATININE RATIO AND ESTIMATED GLOMERULAR FILTRATION RATE IN MATCHED GROUPS OF TYPE 2 DIABETES MELLITUS PATIENTS RECEIVING METFORMIN AND METFORMIN-SULFONYLUREA
International Journal of Applied Pharmaceutics (IJAP)
International Journal of Applied Pharmaceutics, 2020
View PDFchevron_right
Comparison of effect of metformin in combination with glimepiride and glibenclamide on glycaemic control in patient with type 2 diabetes mellitus
Vitthal Kuchake
… Journal of PharmTech …, 2009
View PDFchevron_right
Diabetes Treatment in Patients with Renal Disease—How Many Are Receiving Contraindicated Drugs?
Manel Mata-cases
Diabetes, 2018
View PDFchevron_right
Drug Prescribed To Diabetic Patients And Effectiveness Of Combination And Monotherapy
Dr.Safila Naveed
View PDFchevron_right
Metformin treatment in NIDDM patients with mild renal impairment
Vincent Connolly
Postgraduate Medical Journal, 1996
View PDFchevron_right
Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control
Philip Raskin
Diabetes, Obesity and Metabolism, 2009
View PDFchevron_right
Use of metformin according to renal function in patients with type II diabetes
tahani huria
2021
View PDFchevron_right
Administration of metformin in type 2 diabetes mellitus patients with chronic kidney disease; facts and myths
Steven Kellner
Journal of Nephropathology, 2019
View PDFchevron_right
Evaluation of Efficacy and Tolerability of Gliclazide and Metformin Combination: A Multicentric Study in Patients With Type 2 Diabetes Mellitus Uncontrolled on Monotherapy With Sulfonylurea or Metformin
Navneet Agrawal
American Journal of Therapeutics, 2010
View PDFchevron_right
Glycemic Control in Type 2 Diabetes (Drug Treatments)
Floris Laar
View PDFchevron_right
Combination treatment with metformin and glibenclamide versus single-drug therapies in type 2 diabetes mellitus: a randomized, double-blind, comparative study
Giovanna Spiazzi
Metabolism, 2003
View PDFchevron_right
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
mark jonh
… England Journal of …, 2006
View PDFchevron_right
Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet
Philip Raskin
Diabetes, Obesity and Metabolism, 2009
View PDFchevron_right
Efficacy and Renal Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus Also Receiving Metformin: A Real-Life Experience
vincenzo provenzano , Gabriella Saura , Alessandro Scorsone
2018
View PDFchevron_right
Evaluation of Efficacy and Tolerability of Glimepiride and Metformin Combination
Mangala Borkar
American Journal of Therapeutics, 2013
View PDFchevron_right
Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes
Aine de Bhailis
Therapeutic Advances in Endocrinology and Metabolism, 2021
View PDFchevron_right
Hypoglycaemic Agents in Patients with Heart Failure
Giuseppe M C Rosano
International Cardiovascular Forum Journal
View PDFchevron_right
Updated review: improved glycemic control with repaglinide-metformin in fixed combination for patients with type 2 diabetes
Philip Raskin
Clinical medicine insights. Endocrinology and diabetes, 2011
View PDFchevron_right
Comparison of Metformin-sulfonylurea and Metformin-acarbose Combination Therapies on Glycemic Outcomes: A Retrospective Cohort Study
Wafa Wafa
Current Diabetes Reviews, 2021
View PDFchevron_right
Intensification of Metformin treatment in diabetic patients with Insulin versus Sulfonylureas
Abdollah Mohammadian-Hafshejani
Biomedical Research and Therapy
View PDFchevron_right
Metformin and other antidiabetic agents in renal failure patients
Jean-daniel Lalau
Kidney International, 2014
View PDFchevron_right
Glycemic control with Glyburide/Metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial
mustafa noor
American Journal of Medicine, 2004
View PDFchevron_right
Effect on glycemic control of the addition of 2.5mg glipizide GITS to metformin in patients with T2DM
John Tayek
Diabetes Research and Clinical Practice, 2005
View PDFchevron_right
Spotlight on pharmacology of a noble oral hypoglycaemic agent: Metformin
World Journal of Pharmaceutical Sciences
View PDFchevron_right
Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study
Andrea Burden
View PDFchevron_right
Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus
Maria Teresita Ortiz
Journal of Diabetes and Its Complications, 2009
View PDFchevron_right
Metformin in advanced chronic kidney disease: are current guidelines overly restrictive?
Pauline Swift
British Journal of Diabetes, 2016
View PDFchevron_right
Nateglinide alone or with metformin safely improves glycaemia to target in patients up to an age of 84
Jolanta Weaver
Diabetes, Obesity and Metabolism, 2004
View PDFchevron_right
Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control
Christianne Roumie
Pharmacoepidemiology and Drug Safety, 2013
View PDFchevron_right